Close

Research Insight

Lilly and the William Sansum Diabetes Center announce a five-year research collaboration

Eli Lilly and Company and the William Sansum Diabetes Center have established a research collaboration to improve the lives of Latino people affected by diabetes through enhanced research, education and care. "The tremendous burden of diabetes and cardiovascular disease bears...

Quest Diagnostics collaborates with ADA to help identify people at risk for type 2 diabetes

Quest Diagnostics the world's leading provider of diagnostic information services, including employer health and wellness screening and health improvement services, announced a unique collaboration with the American Diabetes Association aimed at helping more people understand their risk of developing...

University of Pennsylvania announces cancer research alliance with Incyte

The University of Pennsylvania and Incyte Corporation, a Delaware-based biopharmaceutical company, have announced a research alliance to propel advances in cancer biology and immunotherapy. Steven M. Albelda, MD, the William Maul Measey Professor of Medicine, and Gregory L. Beatty,...

American Well Announces Strategic Partnership with Samsung Electronics to Transform Healthcare Acces

At the 17th HIMSS Annual Conference, American Well announced a new strategic partnership with Samsung Electronics. The partnership presents tremendous opportunity for the two organizations to develop new healthcare services for providers, delivery networks, payers, and employers.American Well uses...

ACIB and GE Healthcare establish a cell line engineering collaboration

The Austrian Centre of Industrial Biotechnology (acib) and GE Healthcare are introducing a cell line engineering research collaboration to bring increased productivity to biomanufacturers. The goal of the three-year partnership is to explore and identify new tools and methods...

One Cent Lab on a Chip Technology Developed for Diagnosis of Diseases

Researchers at the Stanford University School of Medicine have developed a way to produce a cheap and reusable diagnostic “lab on a chip” with the help of an ordinary inkjet printer.At a production cost of as little as 1...

BioMarin Receives Access to Priority Medicines support EMA for BMN 270 Gene Therapy in Hemophilia A

BioMarin Pharmaceutical Inc announced that the European Medicines Agency  has granted access to its Priority Medicines (PRIME) regulatory initiative for the company's investigational gene therapy treatment for severe hemophilia A, BMN 270.  To be accepted for PRIME, an investigational...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read